Author Question: What structural part of the story does (3) indicate? a) The Climax b) Enlightenment c) ... (Read 176 times)

erika

  • Hero Member
  • *****
  • Posts: 522
What structural part of the story does (3) indicate?
 
 

a) The Climax
  b) Enlightenment
  c) Disturbance
  d) Major Decision



Question 2

What structural part of the story does (2) indicate?
 
 

a) Complication
  b) Enlightenment
  c) Disturbance
  d) Climax
  e) Major Decision




tmlewis4706

  • Sr. Member
  • ****
  • Posts: 295
Answer to Question 1

d

Answer to Question 2

c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

erika

  • Hero Member
  • *****
  • Posts: 522
Both answers were spot on, thank you once again



tmlewis4706

  • Sr. Member
  • ****
  • Posts: 295

 

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

It is believed that the Incas used anesthesia. Evidence supports the theory that shamans chewed cocoa leaves and drilled holes into the heads of patients (letting evil spirits escape), spitting into the wounds they made. The mixture of cocaine, saliva, and resin numbed the site enough to allow hours of drilling.

Did you know?

It is believed that humans initially contracted crabs from gorillas about 3 million years ago from either sleeping in gorilla nests or eating the apes.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library